Suppr超能文献

用力呼气量(FEV1)日常变化对变化衡量指标的影响:概念描述。

Impact of day-to-day variation in FEV1 on measures of change: A conceptual description.

机构信息

Depts. of Biostatistics, at the University of Washington, Seattle, WA, USA; Pediatrics, at the University of Washington, Seattle, WA, USA; Seattle Children's Research Institute, Seattle, WA, USA.

Depts. of Biostatistics, at the University of Washington, Seattle, WA, USA.

出版信息

J Cyst Fibros. 2024 Sep;23(5):943-946. doi: 10.1016/j.jcf.2024.07.005. Epub 2024 Aug 14.

Abstract

Clinical trials often demonstrate treatment efficacy through change in forced expiratory volume in one second (FEV), comparing single FEV measurements from post- versus pre-treatment timepoints. Day-to-day variation in measured FEV is common for reasons such as diurnal variation and intermittent health changes, relative to a stable, monthly average. This variation can alter estimation of associations between change in FEV and baseline in predictable ways, through a phenomenon called regression to the mean. We quantify and explain day-to-day variation in percent-predicted FEV (ppFEV) from 4 previous trials, and we present a statistical, data-driven explanation for potential bias in ceiling and floor effects due to commonly observed amounts of variation. We recommend accounting for variation when assessing associations between baseline value and change in CF outcomes in single-arm trials, and we consider possible impact of variation on conventional standards for study eligibility.

摘要

临床试验通常通过一秒用力呼气量(FEV)的变化来证明治疗效果,比较治疗前后的单个体FEV 测量值。由于昼夜变化和间歇性健康变化等原因,与稳定的每月平均值相比,测量的 FEV 日常变化很常见。这种变化可以通过一种称为回归均值的现象,以可预测的方式改变 FEV 变化与基线之间关联的估计。我们量化并解释了来自之前 4 项试验的预计百分比 FEV(ppFEV)的日常变化,并对由于常见的变化量而导致的上限和下限效应中的潜在偏差提供了一种统计的、数据驱动的解释。我们建议在评估单臂试验中基线值与 CF 结果变化之间的关联时考虑到这种变化,并考虑变化对研究资格的传统标准的可能影响。

相似文献

3
Exercise versus airway clearance techniques for people with cystic fibrosis.运动与气道廓清技术治疗囊性纤维化。
Cochrane Database Syst Rev. 2022 Jun 22;6(6):CD013285. doi: 10.1002/14651858.CD013285.pub2.
4
Nebulised hypertonic saline for cystic fibrosis.雾化高渗盐水用于囊性纤维化
Cochrane Database Syst Rev. 2018 Sep 27;9(9):CD001506. doi: 10.1002/14651858.CD001506.pub4.
5
Short-acting inhaled bronchodilators for cystic fibrosis.短效吸入性支气管扩张剂在囊性纤维化中的应用。
Cochrane Database Syst Rev. 2022 Jun 24;6(6):CD013666. doi: 10.1002/14651858.CD013666.pub2.
6
Bronchoscopy-guided antimicrobial therapy for cystic fibrosis.支气管镜引导下的囊性纤维化抗菌治疗。
Cochrane Database Syst Rev. 2024 May 3;5(5):CD009530. doi: 10.1002/14651858.CD009530.pub5.
9
Nebulised hypertonic saline for cystic fibrosis.雾化高渗盐水治疗囊性纤维化。
Cochrane Database Syst Rev. 2023 Jun 14;6(6):CD001506. doi: 10.1002/14651858.CD001506.pub5.

本文引用的文献

4
6
Paediatric reproducibility limits for the forced expiratory volume in 1 s.儿童用力呼气量 1 秒的再现性界限。
Thorax. 2020 Oct;75(10):891-896. doi: 10.1136/thoraxjnl-2020-214817. Epub 2020 Aug 11.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验